Belimumab in Autoimmune Hepatitis — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
Canada
University of Calgary, Calgary, Alberta G.I Research Institute, Vancouver, British Columbia McMaster University, Hamilton, Ontario London Health Sciences Centre, London, Ontario Toronto General Hospital, Toronto, Ontario Last updated February 2026